Skip to main content
Log in

Serum β2-microglobulin, sialic acid, and C-reactive protein in systemic lupus erythematosus

  • Originals
  • Published:
Rheumatology International Aims and scope Submit manuscript

Summary

Serum β2-microglobulin (β2m), sialic acid and C-reactive protein (CRP) were studied in 58 patients with systemic lupus erythematosus (SLE) on 186 occasions. Serum β2m was significantly higher in SLE patients than in control subjects. Increased serum β2m levels were seen in 68% of the patients with only extrarenal manifestations of SLE, in 75% of the patients with renal manifestations but normal glomerular filtration rate, and in 100% of the patients with renal failure. Serum β2m levels in 12 SLE patients with associated Sjögren's syndrome were similar to those in patients without that syndrome. Serum sialic acid was also significantly increased in the SLE patients. Sixty-one (33%) of the 186 sera were positive for CRP (⩾5 mg/l). The CRP elevation was not accompanied by recognized intercurrent infection or other superimposed cause of tissue injury and inflammation in 37 instances (61%). Under such conditions CRP was only moderately increased.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Grey HM, Kubo RT, Colon SM, Poulik MD, Cresswell P, Springer T, Turner MJ, Strominger JL (1973) The small subunit of HLA antigens is B2-microglobulin. J Exp Med 138:1608–1612

    Google Scholar 

  2. Poulik MD, Bernoco M, Bernoco D, Creppellini (1973) Aggregation of HLA antigens at the lymphocyte surface induced by antiserum to B2-microglobulin. Science 182: 1352–1355

    Google Scholar 

  3. Peterson PA, Rask L, Lindholm JB (1974) Highly purified papainsolubilized HLA antigens contain B2-microglobulin. Proc Natl Acad Sci USA 71:35–39

    Google Scholar 

  4. Bergg»rd I, Bearn AG (1968) Isolation and properties of a low molecular weight B2-globulin occurring in human biological fluids. J Biol Chem 243:4095–4103

    Google Scholar 

  5. Wibell L, Evrin PE, Bergg»rd I (1973) Serum β2-microglobulin in renal disease. Nephron 10:320–331

    Google Scholar 

  6. Kithies K, Cejka J, Belmarie M (1974) β2-microglobulin occurrence in fetal life and malignancy. Clin Chim Acta 52: 293–299

    Google Scholar 

  7. Schuster J, Gold P, Poulik MD (1976) β2-microglobulin levels in cancerous and other disease states. Clin Chim Acta 67: 307–313

    Google Scholar 

  8. Cooper EH, Bunning R, Illingworth S, Späti B, Child JA (1978) Serial measurement of β2-microglobulin, acute phase reactant proteins and the ESR in non-Hodgkin's lymphomas and chronic lymphocyte leukemia. Biomedicine 29:154–158

    Google Scholar 

  9. Cassuto JP, Krebs BP, Viot G, Dujardin P, Masseyeff R (1978) β2-microglobulin, a tumour marker of lymphoproliferative disorders. Lancet II:108–109.

    Google Scholar 

  10. Simonsson B, Wibell L, Nilsson K (1980) β2-microglobulin in chronic lymphocytic leukemia. Scand J Haematol 24:174–180

    Google Scholar 

  11. Michalski JP, Daniels TE, Talal N, Grey HM (1975) B2-microglobulin and lymphocyte infiltration in Sjögren's syndrome. N Engl J Med 293:1228–1231

    Google Scholar 

  12. Manicourt D, Brauman H, Orloff S (1978) Plasma and urinary levels of β2-microglobulin in rheumatoid arthritis. Ann Rheum Dis 37:328–332

    Google Scholar 

  13. Latt D, Weiss JB, Jayson MIV (1981) β2-microglobulin levels in serum and urine of rheumatoid arthritis patients on gold therapy. Ann Rheum Dis 40:157–160

    Google Scholar 

  14. Kin K, Kasahara T, Itoh Y, Sakurabayashi I, Kaway T, Morita M (1979) β2 microglobulin production by highly purified T and B lymphocytes in cell culture stimulated with various mitogens. Immunology 36:47–54

    Google Scholar 

  15. Decker JL, Steinberg AD, Reinertsen JL, Plotz PH, Balow JE, Klippel JH (1979) Systemic lupus erythematosus: evolving concepts. Ann Intern Med 91:587–604

    Google Scholar 

  16. Cohen AS, Reynolds WE, Franklin CE, Kulka JP, Ropes MW, Shulman LE, Wallace SL (1971) Preliminary criteria for the classification of systemic lupus erythematosus. Bull Rheum Dis 21:643–648

    Google Scholar 

  17. Block KJ, Buchanan WW, Wohl MH (1965) Sjögren's syndrome: a clinical, pathological, and serological study of sixty-two cases. Medicine (Baltimore) 44:187–231

    Google Scholar 

  18. Svennerholm L (1957) Quantitative estimation of sialic acids. II. A colorimetric resorcinol-HCl method. Biochim Biophys Acta 24:604–611

    Google Scholar 

  19. Miettinen TA, Takki-Luukkainen I-T (1959) Use of butyl acetate in determination of sialic acid. Acta Chem Scand 13:856–858

    Google Scholar 

  20. Evrin PE, Wibell L (1973) Serum β2-microglobulin in various disorders. Clin Chim Acta 43:183–187

    Google Scholar 

  21. Weissel M, Scherak O, Fritzsche H, Kolarz G (1976) Serum β2-microglobulin and SLE. Arthritis Rheum 19:968 (Letter to the Editor)

    Google Scholar 

  22. Maury CPJ, Räsänen V, Teppo A-M, Helve T, Wegelius O (in press) Serum pepsinogen I in rheumatic diseases. Reduced levels in Sjögren's syndrome. Arthritis Rheum

  23. Karlsson FA, Groth T, Sege K, Wibell L, Peterson PA (1980) Turnover studies of β2-microglobulin — the constant chain of HLA-antigen. Eur J Clin Invest 10:293–300

    Google Scholar 

  24. Lloyd W, Schur PH (1981) Immune complexes, complement, and anti-DNA in exacerbations of systemic lupus erythematosus (SLE). Medicine 60:208–217

    Google Scholar 

  25. Beorchia S, Vincent C, Revillard JP, Trepo C (1981) Elevation of serum β2-microglobulin in liver diseases. Clin Chim Acta 109:245–255

    Google Scholar 

  26. Mornex JF, Revillard JP, Vincent C, Deteix P, Brune J (1979) Elevated serum β2-microglobulin levels and Clq-binding immune complexes in sarcoidosis. Biomedicine 31:210–213

    Google Scholar 

  27. Maury CPJ, Sjöblom C, Wegelius O (1981) Urinary excretion of sialic acid-containing saccharides in systemic lupus erythematosus. Arthritis Rheum 24:1137–1141

    Google Scholar 

  28. Maury CPJ, Teppo A-M, Wegelius O (1982) Relationship between urinary sialylated saccharides, serum amyloid A protein and C-reactive protein in rheumatoid arthritis and systemic lupus erythematosus. Ann Rheum Dis 41:268–271

    Google Scholar 

  29. Becker GJ, Waldburger M, Hughes GRV, Pepys MB (1980) Value of C-reactive protein measurement in the investigation of fever in systemic lupus erythematosus. Ann Rheum Dis 39:50–52

    Google Scholar 

  30. Morrow WJW, Isenberg DA, Parry HF, Snaith ML (1981) C-reactive protein in sera from patients with systemic lupus erythematosus. J Rheumatol 8:599–604

    Google Scholar 

  31. Pepys MB, Dash AC, Markham RE, Thomas HC, Williams BD, Petrie A (1978) Comparative clinical study of protein SAP (amyloid P component) and C-reactive protein in serum. Clin Exp Immunol 32:119–124

    Google Scholar 

  32. Honig S, Gorevic P, Weissman G (1977) C-reactive protein in systemic lupus erythematosus. Arthritis Rheum 20:1065–1070

    Google Scholar 

  33. Zein N, Ganuza C, Kushner I (1979) Significance of serum C-reactive protein elevation in patients with systemic lupus erythematosus. Arthritis Rheum 22:7–12

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Maury, C.P.J., Helve, T. & Sjöblom, C. Serum β2-microglobulin, sialic acid, and C-reactive protein in systemic lupus erythematosus. Rheumatol Int 2, 145–149 (1982). https://doi.org/10.1007/BF00286135

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00286135

Key words

Navigation